(a) All information and data obtained by the Board under this subtitle, that is not otherwise publicly available:
(1) Is considered to be a trade secret and confidential and proprietary information; and
(2) Is not subject to disclosure under the Public Information Act.
(b) Only Board members and staff may access trade secrets and confidential and proprietary data and information obtained under this subtitle that is not otherwise publicly available.
(c) The provisions of Title 11, Subtitle 12 of the Commercial Law Article shall apply to any trade secrets and confidential and proprietary data and information obtained under this subtitle that is not otherwise publicly available.
Structure Maryland Statutes
Title 21 - Food, Drugs, and Cosmetics
Subtitle 2C - Prescription Drug Affordability Board
Section 21-2C-01 - Definitions
Section 21-2C-02 - Prescription Drug Affordability Board
Section 21-2C-04 - Prescription Drug Affordability Stakeholder Council
Section 21-2C-05 - Disclosure of Conflicts of Interest
Section 21-2C-06 - Acceptance of Gratuities Prohibited
Section 21-2C-08 - Collection, Review, and Use of Transparency Data for Prescription Drug Products
Section 21-2C-09 - Cost Review of Prescription Drug Products With Affordability Challenges
Section 21-2C-10 - Confidentiality
Section 21-2C-11 - Funding Source
Section 21-2C-12 - Enforcement
Section 21-2C-14 - Setting Upper Payment Limits for Prescription Drug Products